Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer
Authors
Keywords
Breast cancer therapeutics, Bax activators, Anticancer agents, Drug discovery, Apoptosis
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 219, Issue -, Pages 113427
Publisher
Elsevier BV
Online
2021-04-04
DOI
10.1016/j.ejmech.2021.113427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Applications of Bioorthogonal Chemistry in Tumor-Targeted Drug Discovery
- (2019) Gang Liu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer
- (2019) Gang Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nitro-Group-Containing Drugs
- (2018) Kunal Nepali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Quinoline–Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity
- (2018) Wenlong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders
- (2017) Satoshi Mikami et al. JOURNAL OF MEDICINAL CHEMISTRY
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Palladium-Catalyzed Formal [4 + 1] Annulation via Metal Carbene Migratory Insertion and C(sp2)–H Bond Functionalization
- (2017) Shuai Xu et al. ACS Catalysis
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Direct Activation of Bax Protein for Cancer Therapy
- (2015) Zhiqing Liu et al. MEDICINAL RESEARCH REVIEWS
- Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group
- (2015) Núbia Boechat et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Practical olefin hydroamination with nitroarenes
- (2015) J. Gui et al. SCIENCE
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- Small-molecule Bax agonists for cancer therapy
- (2014) Meiguo Xin et al. Nature Communications
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Mechanistic insights into the cytotoxicity and genotoxicity induced by glycidamide in human mammary cells
- (2013) S. Bandarra et al. MUTAGENESIS
- Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol
- (2011) Frank Edlich et al. CELL
- Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells
- (2011) J. G. Valero et al. JOURNAL OF CELL SCIENCE
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore
- (2011) Loren D. Walensky et al. TRENDS IN BIOCHEMICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started